Abstract
Recent data have raised concerns about the safety of drug-eluting stents.1 Stents are used in over 70% of percutaneous coronary interventions (PCIs) because they reduce the risk of acute major complications of PCI and long-term restenosis. Despite the low procedural morbidity afforded by stenting, coronary artery bypass graft (CABG) surgery offers significantly greater freedom from angina, repeat revascularization, myocardial infarction, stroke, and death in the treatment of multivessel ischaemic heart disease.2 Stenting has, however, become first line treatment in increasing numbers of patients that are surgical candidates. Many of these patients eventually require coronary artery surgery: …
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
